Exploiting lipid raft transport with membrane targeted nanoparticles: A strategy for cytosolic drug delivery
- 16 May 2008
- journal article
- Published by Elsevier in Biomaterials
- Vol. 29 (23), 3367-3375
- https://doi.org/10.1016/j.biomaterials.2008.04.030
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Imaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticlesInternational Journal of Cancer, 2007
- Potential Use of Fluorocarbons in Lung Surfactant TherapyArtificial Cells, Blood Substitutes, and Immobilization Biotechnology, 2007
- Endothelial α ν β 3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Hyperthermia mediated liposomal drug deliveryInternational Journal of Hyperthermia, 2006
- Lipid traffic: floppy drives and a superhighwayNature Reviews Molecular Cell Biology, 2005
- Ganglioside GM1 levels are a determinant of the extent of caveolae/raft-dependent endocytosis of cholera toxin to the Golgi apparatusJournal of Cell Science, 2004
- Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progressDrug Discovery Today, 2004
- Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine developmentAdvanced Drug Delivery Reviews, 2001
- Analysis of Ostwald Ripening in Fluorocarbon Emulsions by Sedimentation Field-Flow FractionationArtificial Cells, Blood Substitutes, and Immobilization Biotechnology, 1994
- Effects of cytochalasin and phalloidin on actin.The Journal of cell biology, 1987